Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: Maintenance is necessary to sustain response

Leukemia and Lymphoma

Volumn 40, Issue 1-2, 2000, Pages 141-147

  Siakantaris, Marina P ^a   Angelopoulou, Maria K ^a   Vassilakopoulos, Theodoros P ^a   Dimopoulou, Maria N ^a   Kontopidou, Flora N ^a   Pangalis, Gerassimos A ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Anaemia of B cell lymphoproliferative disorders; B CLL; Disease related anaemia; Human recombinant erythropoietin; Small cell lymphoma

Indexed keywords

CHLORAMBUCIL; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; B CELL LEUKEMIA; BONE MARROW; CANCER INFILTRATION; CANCER RECURRENCE; CANCER STAGING; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; LYMPHATIC LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SPLENOMEGALY; SURVIVAL;

EID: 0035126147     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009054891     Document Type: Article

References (20)

1. Pangalis GA, Boussiotis VA, Kittas Ch (1993). Malignant disorders of small lymphocytes. Small lymphocytic lymphoma, lymphoplasmacytic lymphoma and chronic lymphocytic leukemia: Their clinical and laboratory relationship. Am J Clin Pathol 99: 402-408, 1993.
2. Pangalis GA, Angelopoulou MK, Vassilakopoulos ThP, Siakantaris MP, Kittas CH (1999). B-chronic lymphocytic leukemia, small lymphocytic lymphoma, lymphoplasmacytc lymphoma and Waldenstrom's macroglobulinemia: A clinical, morphologic and biologic spectrum of similar disorders. Semin Hematol 36: 104-114.
3. Hallberg L, Harwerth HG, Vannoti A (1970). Iron deficiency, pathogenesis, clinical aspects, therapy. Academic press, London.
4. th Edition, McGrawHill Companies, USA.
5. Majumdar G, Brown S, Slater NG, Singh AK (1992). Clinical spectrum of auto-immune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Leuk Lymphoma 9: 149-151.
6. Diehl LF, Ketshum LH (1998). Autoimmune disease and chronic lymphocytic leukemia: Autoimmune hemolytic anemia, pure red cell aplasia and autoimmune thrombocytopenia. Semin Oncol 25: 80-97.
7. Means RT Jr, Krantz SB (1992). Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80: 1639-1647.
8. Lee GR (1983). The anemia of chronic disease. Semin Hematol 20: 61-80.
9. Siakantaris MP, Samaras IT, Angelopoulou MK, Kontopidou FN, Pangalis GA (1999). The role of cytokines in the supportive care of oncology patients. Haema 2: 64-82.
10. Glapsy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Roj S (1997). Impact of therapy with epoetin alfa on clinical outcome in patients with non-myeloid malignancies during cancer chmotherapy in community oncology practice. J Clin Oncol 15: 1218-1234.
11. Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, Barnas U (1990). Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322: 1693-1699.
12. Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, Mulelr G, Brune T, Kraemer HP, Mertelsmann R (1990). Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 8: 956-962.
13. Pangalis GA, Poziopoulos Ch, Angelopoulou MK, Siakantaris MP, Panayiotidis P (1995). Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin. Br J Haematol 89: 627-629.
14. Boussiotis VA, Panayiotidis PG, Pangalis GA (1991). Prolonged intermittent chlorambucil administration in B-chronic lymphocytic leukemia: Experience from a Single Hematology Unit. Leuk Lymphoma 5 (Suppl. 1): 113-117.
15. Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jager G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B (1995). Recombinat human erythropietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: Dose finding and identification of predictors of response. Blood 86: 4446-4453.
16. Moullet I, Salles G, Ketterer N, Dumontent C, Bouafia F, Neidhart-Berard EM, Thieblemont C, Felman P, Coiffier B (1998): Frequency and significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol 9: 1109-1115.
17. Conlan MG, Armitage JO, Bast M, Weisenburger DD (1991). Clinical significance of hematologic parameters in non-Hodgkin's lymphoma at diagnosis. Cancer 67: 1389-1395.
18. Beguin Y (1996). Eryhtropoietin and the anemia of cancer. Acta Clin Belg 51: 36-52.
19. Douglas SW, Adamson JW (1975). The anemia of chronic disorders: Studies of marrow regulation and iron metabolism. Blood 45: 55-65.
20. Finch CA (1982). Erythropoiesis, erythropoietin and iron. Blood 60: 1241-1246.